Merck Animal Health, the global animal health business unit of Merck & Co., Inc. (NYSE:MRK) said that the U.S. Food and Drug Administration has approved Bravecto or fluralaner chewable tablets for dogs (112.5 mg, 250 mg, 500 mg, 1000 mg, 1400 mg). Merck & Co., Inc. (NYSE:MRK) net profit margin is 14.00% and weekly performance is 0.37%. On last trading day company shares ended up $56.58. Analysts mean target price for the company is $59.22. Merck & Co., Inc. (NYSE:MRK) distance from 50-day simple moving average (SMA50) is 0.42%.
Pfizer’s (NYSE:PFZ) $120 billion offer for British rival AstraZeneca (NYSE: AZN $74.37) has raised concerns Pfizer is about to do what it always does after a big acquisition. Pfizer Inc. (NYSE:PFE) shares advanced 1.09% in last trading session and ended the day on $29.57. Gross Margin is 81.90% and its return on assets is 23.00%. Pfizer Inc. (NYSE:PFE) quarterly performance is -5.44%.
Eli Lilly and Company (NYSE:LLY) will conduct a conference call on June 3, 2014 for the media and investment community to review select data presented at the 2014 Annual Meeting of the American Society of Clinical Oncology (ASCO). Eli Lilly and Co (NYSE:LLY) shares moved up 0.70% in last trading session and was closed at $59.07, while trading in range of $58.65 – $59.10. Eli Lilly and Co (NYSE:LLY) year to date (YTD) performance is 17.86%.
Novartis AG (ADR) (NYSE:NVS)’s heart-failure medication failed to win U.S. approval, setting back the company’s plan to build a portfolio of cardiac therapies around the drug. The Food and Drug Administration asked for more information about the medicine called serelaxin, according to a statement from the company. A panel of advisers to the FDA unanimously recommended against approval March 27. They agreed with FDA staff members who said in a March 25 report they found insufficient evidence that serelaxin will benefit patients. Novartis said it will expedite a program of clinical trials to gather more evidence. Novartis AG (ADR) (NYSE:NVS) ended the last trading day at $89.49. Company weekly volatility is calculated as 0.57% and price to cash ratio as 31.41. Novartis AG (ADR) (NYSE:NVS) showed a positive weekly performance of 0.28%.
Wipro Ltd., the information technology leader has entered into a strategic partnership with Takeda Pharmaceutical Company Ltd. (ADR) (OTCMKTS:TKPYY), the largest pharmaceutical company in Japan and one of the global leaders of the industry. Takeda Pharmaceutical Co Ltd (ADR) (OTCMKTS:TKPYY) On last trading day company shares ended up $22.17.
Leave a Reply